Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction

Eriocalyxin B (EriB), a potent ent-kaurene extracted from Isodon eriocalyx, has turned up as novel anti-cancer agent during recent years against a range of cancer types. TNBC (Triple negative breast cancer) is highly aggressive breast cancer, which is resistant towards current therapeutics due to ab...

Full description

Saved in:
Bibliographic Details
Published in:Pakistan journal of pharmaceutical sciences 2019-11, Vol.32 (6(Supplementary)), p.2843-2848
Main Authors: Riaz, Ammara, Rasul, Azhar, Hussain, Ghulam, Zubair, Muhammad, Samiullah, Khizar, Sarfraz, Iqra, Masood, Muqaddas, Jabeen, Farhat, Sultana, Tayyaba, Sultana, Salma
Format: Article
Language:English
Subjects:
Anopheles
Apoptosis
Breast cancer
Cancer cells
Cancer treatment
Novels
Therapeutics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 2848
container_issue 6(Supplementary)
container_start_page 2843
container_title Pakistan journal of pharmaceutical sciences
container_volume 32
creator Riaz, Ammara
Rasul, Azhar
Hussain, Ghulam
Zubair, Muhammad
Samiullah, Khizar
Sarfraz, Iqra
Masood, Muqaddas
Jabeen, Farhat
Sultana, Tayyaba
Sultana, Salma
description Eriocalyxin B (EriB), a potent ent-kaurene extracted from Isodon eriocalyx, has turned up as novel anti-cancer agent during recent years against a range of cancer types. TNBC (Triple negative breast cancer) is highly aggressive breast cancer, which is resistant towards current therapeutics due to absence of drug targets. Here, we have probed the molecular mechanism of EriB-induced apoptosis in TNBC (MDA-MB231) cells to check whether its anticancer activity is mediated by modulation of STAT3 and NF-ϰB. EriB induced apoptosis in MDA-MB231 cells via inhibiting NF-ϰBp65, STAT3 phosphorylation, increasing Bax/Bcl-2 ratio, MMP dissipation, and activation of caspase-3. These results provide a rationale for further in vivo investigations on EriB, which might also prove to be a potential drug candidate for developing novel therapeutics against TNBC.
doi_str_mv 10.36721/PJPS.2019.32.6.SUP.2843-2848.1
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2352051624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A612928752</galeid><sourcerecordid>A612928752</sourcerecordid><originalsourceid>FETCH-LOGICAL-g250t-5337eabe77078a768287e74ce5dc2fcb992710a4c90691a33d54a2013e4cae973</originalsourceid><addsrcrecordid>eNo1UF1r3DAQ9ENLk6b5C0Fv7YsdfdiS9XgNaZIS6MFdoG9mLa_vVGzJleTQ-wv91VVIysIuzM4MwxTFZ0YrIRVn19vv213FKdOV4JWsdk_bire1KPNqK_auOGeUsVJS9vOs-BjjL0plrbX-UJwJTnktuTgv_t4G6w1Mpz_Wka_EumE1GAksfkk-2pgRclxncCQFu0xIHB4g2WckfUCIiRhwBgMxOE2RPFvIgqPtbbLuQHb7zV4QMJmfNd4RcAOZbfLm6N0QLExkOMVxdebl-6l4P8IU8fLtXhRP3273N_fl44-7h5vNY3ngDU1lI4RC6FEpqlpQsuWtQlUbbAbDR9NrzRWjUBtNpWYgxNDUkFsSWBtArcRF8eXVdwn-94oxdbONL_nBoV9jx0XDacMkrzO1eqUeYMLOutGnACbPgLM13uFoM76RjOucouFZcPXmvfYzDt0S7Azh1P0vXPwDBlmGIg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2352051624</pqid></control><display><type>article</type><title>Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction</title><source>EZB Electronic Journals Library</source><creator>Riaz, Ammara ; Rasul, Azhar ; Hussain, Ghulam ; Zubair, Muhammad ; Samiullah, Khizar ; Sarfraz, Iqra ; Masood, Muqaddas ; Jabeen, Farhat ; Sultana, Tayyaba ; Sultana, Salma</creator><creatorcontrib>Riaz, Ammara ; Rasul, Azhar ; Hussain, Ghulam ; Zubair, Muhammad ; Samiullah, Khizar ; Sarfraz, Iqra ; Masood, Muqaddas ; Jabeen, Farhat ; Sultana, Tayyaba ; Sultana, Salma</creatorcontrib><description>Eriocalyxin B (EriB), a potent ent-kaurene extracted from Isodon eriocalyx, has turned up as novel anti-cancer agent during recent years against a range of cancer types. TNBC (Triple negative breast cancer) is highly aggressive breast cancer, which is resistant towards current therapeutics due to absence of drug targets. Here, we have probed the molecular mechanism of EriB-induced apoptosis in TNBC (MDA-MB231) cells to check whether its anticancer activity is mediated by modulation of STAT3 and NF-ϰB. EriB induced apoptosis in MDA-MB231 cells via inhibiting NF-ϰBp65, STAT3 phosphorylation, increasing Bax/Bcl-2 ratio, MMP dissipation, and activation of caspase-3. These results provide a rationale for further in vivo investigations on EriB, which might also prove to be a potential drug candidate for developing novel therapeutics against TNBC.</description><identifier>ISSN: 1011-601X</identifier><identifier>DOI: 10.36721/PJPS.2019.32.6.SUP.2843-2848.1</identifier><identifier>PMID: 32024623</identifier><language>eng</language><publisher>Pakistan: Pakistan Journal of Pharmaceutical Sciences</publisher><subject>Anopheles ; Apoptosis ; Breast cancer ; Cancer cells ; Cancer treatment ; Novels ; Therapeutics</subject><ispartof>Pakistan journal of pharmaceutical sciences, 2019-11, Vol.32 (6(Supplementary)), p.2843-2848</ispartof><rights>COPYRIGHT 2019 Pakistan Journal of Pharmaceutical Sciences</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32024623$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riaz, Ammara</creatorcontrib><creatorcontrib>Rasul, Azhar</creatorcontrib><creatorcontrib>Hussain, Ghulam</creatorcontrib><creatorcontrib>Zubair, Muhammad</creatorcontrib><creatorcontrib>Samiullah, Khizar</creatorcontrib><creatorcontrib>Sarfraz, Iqra</creatorcontrib><creatorcontrib>Masood, Muqaddas</creatorcontrib><creatorcontrib>Jabeen, Farhat</creatorcontrib><creatorcontrib>Sultana, Tayyaba</creatorcontrib><creatorcontrib>Sultana, Salma</creatorcontrib><title>Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction</title><title>Pakistan journal of pharmaceutical sciences</title><addtitle>Pak J Pharm Sci</addtitle><description>Eriocalyxin B (EriB), a potent ent-kaurene extracted from Isodon eriocalyx, has turned up as novel anti-cancer agent during recent years against a range of cancer types. TNBC (Triple negative breast cancer) is highly aggressive breast cancer, which is resistant towards current therapeutics due to absence of drug targets. Here, we have probed the molecular mechanism of EriB-induced apoptosis in TNBC (MDA-MB231) cells to check whether its anticancer activity is mediated by modulation of STAT3 and NF-ϰB. EriB induced apoptosis in MDA-MB231 cells via inhibiting NF-ϰBp65, STAT3 phosphorylation, increasing Bax/Bcl-2 ratio, MMP dissipation, and activation of caspase-3. These results provide a rationale for further in vivo investigations on EriB, which might also prove to be a potential drug candidate for developing novel therapeutics against TNBC.</description><subject>Anopheles</subject><subject>Apoptosis</subject><subject>Breast cancer</subject><subject>Cancer cells</subject><subject>Cancer treatment</subject><subject>Novels</subject><subject>Therapeutics</subject><issn>1011-601X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo1UF1r3DAQ9ENLk6b5C0Fv7YsdfdiS9XgNaZIS6MFdoG9mLa_vVGzJleTQ-wv91VVIysIuzM4MwxTFZ0YrIRVn19vv213FKdOV4JWsdk_bire1KPNqK_auOGeUsVJS9vOs-BjjL0plrbX-UJwJTnktuTgv_t4G6w1Mpz_Wka_EumE1GAksfkk-2pgRclxncCQFu0xIHB4g2WckfUCIiRhwBgMxOE2RPFvIgqPtbbLuQHb7zV4QMJmfNd4RcAOZbfLm6N0QLExkOMVxdebl-6l4P8IU8fLtXhRP3273N_fl44-7h5vNY3ngDU1lI4RC6FEpqlpQsuWtQlUbbAbDR9NrzRWjUBtNpWYgxNDUkFsSWBtArcRF8eXVdwn-94oxdbONL_nBoV9jx0XDacMkrzO1eqUeYMLOutGnACbPgLM13uFoM76RjOucouFZcPXmvfYzDt0S7Azh1P0vXPwDBlmGIg</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Riaz, Ammara</creator><creator>Rasul, Azhar</creator><creator>Hussain, Ghulam</creator><creator>Zubair, Muhammad</creator><creator>Samiullah, Khizar</creator><creator>Sarfraz, Iqra</creator><creator>Masood, Muqaddas</creator><creator>Jabeen, Farhat</creator><creator>Sultana, Tayyaba</creator><creator>Sultana, Salma</creator><general>Pakistan Journal of Pharmaceutical Sciences</general><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20191101</creationdate><title>Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction</title><author>Riaz, Ammara ; Rasul, Azhar ; Hussain, Ghulam ; Zubair, Muhammad ; Samiullah, Khizar ; Sarfraz, Iqra ; Masood, Muqaddas ; Jabeen, Farhat ; Sultana, Tayyaba ; Sultana, Salma</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g250t-5337eabe77078a768287e74ce5dc2fcb992710a4c90691a33d54a2013e4cae973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anopheles</topic><topic>Apoptosis</topic><topic>Breast cancer</topic><topic>Cancer cells</topic><topic>Cancer treatment</topic><topic>Novels</topic><topic>Therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riaz, Ammara</creatorcontrib><creatorcontrib>Rasul, Azhar</creatorcontrib><creatorcontrib>Hussain, Ghulam</creatorcontrib><creatorcontrib>Zubair, Muhammad</creatorcontrib><creatorcontrib>Samiullah, Khizar</creatorcontrib><creatorcontrib>Sarfraz, Iqra</creatorcontrib><creatorcontrib>Masood, Muqaddas</creatorcontrib><creatorcontrib>Jabeen, Farhat</creatorcontrib><creatorcontrib>Sultana, Tayyaba</creatorcontrib><creatorcontrib>Sultana, Salma</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pakistan journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riaz, Ammara</au><au>Rasul, Azhar</au><au>Hussain, Ghulam</au><au>Zubair, Muhammad</au><au>Samiullah, Khizar</au><au>Sarfraz, Iqra</au><au>Masood, Muqaddas</au><au>Jabeen, Farhat</au><au>Sultana, Tayyaba</au><au>Sultana, Salma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction</atitle><jtitle>Pakistan journal of pharmaceutical sciences</jtitle><addtitle>Pak J Pharm Sci</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>32</volume><issue>6(Supplementary)</issue><spage>2843</spage><epage>2848</epage><pages>2843-2848</pages><issn>1011-601X</issn><abstract>Eriocalyxin B (EriB), a potent ent-kaurene extracted from Isodon eriocalyx, has turned up as novel anti-cancer agent during recent years against a range of cancer types. TNBC (Triple negative breast cancer) is highly aggressive breast cancer, which is resistant towards current therapeutics due to absence of drug targets. Here, we have probed the molecular mechanism of EriB-induced apoptosis in TNBC (MDA-MB231) cells to check whether its anticancer activity is mediated by modulation of STAT3 and NF-ϰB. EriB induced apoptosis in MDA-MB231 cells via inhibiting NF-ϰBp65, STAT3 phosphorylation, increasing Bax/Bcl-2 ratio, MMP dissipation, and activation of caspase-3. These results provide a rationale for further in vivo investigations on EriB, which might also prove to be a potential drug candidate for developing novel therapeutics against TNBC.</abstract><cop>Pakistan</cop><pub>Pakistan Journal of Pharmaceutical Sciences</pub><pmid>32024623</pmid><doi>10.36721/PJPS.2019.32.6.SUP.2843-2848.1</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1011-601X
ispartof Pakistan journal of pharmaceutical sciences, 2019-11, Vol.32 (6(Supplementary)), p.2843-2848
issn 1011-601X
language eng
recordid cdi_proquest_miscellaneous_2352051624
source EZB Electronic Journals Library
subjects Anopheles
Apoptosis
Breast cancer
Cancer cells
Cancer treatment
Novels
Therapeutics
title Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A50%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eriocalyxin%20B%20induces%20apoptosis%20in%20human%20triple%20negative%20breast%20cancer%20cells%20via%20inhibiting%20STAT3%20activation%20and%20mitochondrial%20dysfunction&rft.jtitle=Pakistan%20journal%20of%20pharmaceutical%20sciences&rft.au=Riaz,%20Ammara&rft.date=2019-11-01&rft.volume=32&rft.issue=6(Supplementary)&rft.spage=2843&rft.epage=2848&rft.pages=2843-2848&rft.issn=1011-601X&rft_id=info:doi/10.36721/PJPS.2019.32.6.SUP.2843-2848.1&rft_dat=%3Cgale_proqu%3EA612928752%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g250t-5337eabe77078a768287e74ce5dc2fcb992710a4c90691a33d54a2013e4cae973%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2352051624&rft_id=info:pmid/32024623&rft_galeid=A612928752&rfr_iscdi=true